The cartographic invisibility of the Šaranska river in Kosovo and Metohija
Zbornik radova - Geografski fakultet Univerziteta u Beogradu · 2025 · (73) · 75-105
DOI: 10.5937/zrgfub2573075m ↗Kurz gefasst
Fachartikel in der Zeitschrift Zbornik radova - Geografski fakultet Univerziteta u Beogradu, 2025. Verfasst von Ivan Matejić. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In the basin of the Binačka Morava (Binač Morava) in Kosovo and Metohija lies the Šaranska River, which flows into it as a left tributary. It is about 23 kilometers long and begins in the territory of the municipality of Gnjilane, in the area of the village of Paralovo. On geographical maps along its course, the hydronyms Brasaljska reka and Livočka reka are inscribed. The main focus of this paper is the analysis of available cartographic and written material about the Šaranska River, as well as a comparison with data collected during field research of its valley and the course itself. The paper aims to determine the occurrence of the hydronym Šaranska Reka on geographical maps throughout history and field research of its valley with a survey of the local population on the use of the hydronym Šaranska Reka, as well as laying the foundations for similar research in the future.
Zitieren
APA
Matejić, I. (2025). The cartographic invisibility of the Šaranska river in Kosovo and Metohija. Zbornik radova - Geografski fakultet Univerziteta u Beogradu, 75-105. https://doi.org/10.5937/zrgfub2573075m
Vancouver
Matejić I. The cartographic invisibility of the Šaranska river in Kosovo and Metohija. Zbornik radova - Geografski fakultet Univerziteta u Beogradu. 2025:75-105. doi:10.5937/zrgfub2573075m
BibTeX
@article{Mateji2025,
author = {Matejić, Ivan},
title = {The cartographic invisibility of the Šaranska river in Kosovo and Metohija},
journal = {Zbornik radova - Geografski fakultet Univerziteta u Beogradu},
year = {2025},
number = {73},
pages = {75--105},
doi = {10.5937/zrgfub2573075m}
}
EUVIMED